Financhill
Sell
36

OXSQ Quote, Financials, Valuation and Earnings

Last price:
$2.46
Seasonality move :
-1.27%
Day range:
$2.44 - $2.50
52-week range:
$2.28 - $3.28
Dividend yield:
17.07%
P/E ratio:
246.00x
P/S ratio:
46.96x
P/B ratio:
1.18x
Volume:
591.2K
Avg. volume:
471K
1-year change:
-22.64%
Market cap:
$175.6M
Revenue:
$10M
EPS (TTM):
$0.01

Earnings Data

Next earnings date for OXSQ
Aug 13
2025
Most recent earnings per share
-$0.12
Missed by $0.20
(Apr 25/2025)
Consensus Estimate
$0.08
(Apr 25/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OXSQ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/13/2025 Q2 $10M -- -- $0.08 --
04/25/2025 Q1 $9.9M -$7.1M -$0.12 $0.08 -$0.20
02/28/2025 Q4 $9.9M $4.3M $0.05 $0.06 -$0.01
11/05/2024 Q3 $11.7M $233.2K -$0.01 $0.12 -$0.13
08/13/2024 Q2 $12M $6M $0.09 $0.13 -$0.04
05/02/2024 Q1 $12M -$577.3K -$0.03 $0.13 -$0.16
03/15/2024 Q4 -- -$5.9M -$0.15 -- --
11/07/2023 Q3 -- -- $0.12 $0.12 --
08/10/2023 Q2 -- -- $0.23 $0.12 $0.11
05/02/2023 Q1 -- -- $0.13 $0.11 $0.02
03/21/2023 Q4 -- -- -$0.46 $0.13 -$0.59
11/07/2022 Q3 -- -- -$0.22 $0.11 -$0.33
07/26/2022 Q2 -- -- -$0.78 $0.08 -$0.86
04/28/2022 Q1 -- -- -$0.16 $0.08 -$0.24
03/03/2022 Q4 -- -- -- $0.09 --
10/26/2021 Q3 -- -- $0.23 $0.09 $0.14
07/27/2021 Q2 -- -- $0.13 $0.11 $0.02
04/27/2021 Q1 -- -- $0.44 $0.09 $0.35
03/22/2021 Q4 -- -- $0.80 $0.09 $0.71
10/27/2020 Q3 -- -- $0.42 $0.08 $0.34
07/28/2020 Q2 -- -- $0.41 $0.11 $0.30
04/28/2020 Q1 -- -- -$1.62 $0.17 -$1.79
02/26/2020 Q4 -- -- -$0.10 $0.19 -$0.29
10/30/2019 Q3 -- -- -$0.69 $0.18 -$0.87
07/30/2019 Q2 -- -- -$0.16 $0.18 -$0.33
04/30/2019 Q1 -- -- $0.27 $0.17 $0.10
02/28/2019 Q4 -- -- -$0.69 $0.18 -$0.87
10/30/2018 Q3 -- -- $0.13 -- --
07/31/2018 Q2 -- -- $0.14 -- --
05/01/2018 Q1 -- -- $0.22 -- --
02/27/2018 Q4 -- -- $0.30 -- --
11/02/2017 Q3 -- -- $0.12 -- --
08/08/2017 Q2 -- -- $0.18 -- --
05/08/2017 Q1 -- -- $0.23 -- --
03/02/2017 Q4 -- -- $0.62 -- --
11/03/2016 Q3 -- -- $0.72 -- --
08/04/2016 Q2 -- -- $0.81 -- --
05/03/2016 Q1 -- -- -$0.32 -- --
03/10/2016 Q4 -- -- -$1.13 -- --
11/06/2015 Q3 -- -- -$0.50 -- --
08/04/2015 Q2 -- -- $0.17 -- --

Oxford Square Capital Earnings Questions

  • How Much did Oxford Square Capital Generate in Revenue Last Quarter?

    Oxford Square Capital reported -$7.1M worth of top line sales in its most recent quarter.

  • Did Oxford Square Capital Beat Earnings Last Quarter?

    Oxford Square Capital announced earnings per share of -$0.12 which represents a miss of analyst forecast a $0.08 per share.

  • Is Oxford Square Capital Profitable?

    Oxford Square Capital reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Oxford Square Capital EPS Next Year?

    Oxford Square Capital's earnings are forecast to grow from $0.09 per share to $0.32 per share next year representing an increase of 255.56%.

  • When is Oxford Square Capital's Earnings Date?

    Oxford Square Capital's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock